Author(s): Antreas Afantitis, Iseult Lynch
Publication: Bunsen-Magazin, Issue 2 2021, Seiten: 78-80
Publisher: Deutsche Bunsen-Gesellschaft für physikalische Chemie e.V., Frankfurt
Language: English
DOI: 10.26125/zjfv-3s10
Abstract
Nanotechnology is a key enabling technology, capable of delivering a wide range of technological breakthroughs across all EU priority sectors. Production of novel and emerging engineered and manufactured nanomaterials (NMs) is fundamental to advances in aeronautics, construction, electronics and consumer good. Although numerous benefi ts of NMs have been identified over the last decades, concerns are also arising as risk assessment lags behind product development, mainly because current approaches to assessing exposure, hazard and risk are expensive, time-consuming, and frequently involve testing in animal models. Additionally, the test guidance documents for generating regulatory-compliant data are still being updated for nanomaterials, whose surface reactivity and interactions with biomolecules and cellular machinery makes their assessment challenging compared to molecular chemicals. This leaves industry in the challenging position of having to provide data but how to generate the required data is not always clear.
Cite this: Afantitis, Antreas, Lynch, Iseult (2021): Digitising nanomaterials safety assessment - innovative nanoinformatics data workflows, models and tools for predictive nanomaterials (eco)toxicology. Bunsen-Magazin 2021, 2: 78-80. Frankfurt am Main: Deutsche Bunsen-Gesellschaft für physikalische Chemie e.V. DOI: 10.26125/zjfv-3s10
[1] Papadiamantis et al., Predicting Cytotoxicity of Metal Oxide Nanoparticles Using Isalos Analytics Platform. Nanomaterials 2020, 10(10), 2017; doi.org/10.3390/nano10102017
[2] Lynch et al., Can an InChI for Nano Address the Need for a Simplified Representation of Complex Nanomaterials across Experimental and Nanoinformatics Studies? Nanomaterials 2020, 10(12), 2493; doi.org/10.3390/nano10122493;
[3] Kinaret et al., Transcriptomics in Toxicogenomics, Part I: Experimental Design, Technologies, Publicly Available Data, and Regulatory Aspects. Nanomaterials 2020, 10(4), 750; doi.org/10.3390/nano10040750;
[4] Federico et al., Transcriptomics in Toxicogenomics, Part II: Preprocessing and Differential Expression Analysis for High Quality Data. Nanomaterials 2020, 10(5), 903; doi.org/10.3390/nano10050903;
[5] Serra et al., Transcriptomics in Toxicogenomics, Part III: Data Modelling for Risk Assessment. Nanomaterials 2020, 10(4), 708; doi.org/10.3390/nano10040708;
[6] Karatzas et al., Development of Deep Learning Models for Predicting the Effects of Exposure to Engineered Nanomaterials on Daphnia magna. Small, 2020, 16 (36), 2001080; doi.org/10.1002/smll.202001080.
Download the full article